Marshall Wace North America’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $4.51M | Buy |
+10,895
| New | +$4.51M | 0.02% | 534 |
|
|
2020
Q1 | – | Sell |
-2,422
| Closed | -$701K | – | 1655 |
|
|
2019
Q4 | $701K | Buy |
+2,422
| New | +$701K | ﹤0.01% | 772 |
|
|
2018
Q3 | – | Sell |
-2,011
| Closed | -$816K | – | 1430 |
|
|
2018
Q2 | $816K | Sell |
2,011
-2,473
| -55% | -$1M | ﹤0.01% | 983 |
|
|
2018
Q1 | $2.45M | Buy |
+4,484
| New | +$2.45M | 0.01% | 756 |
|
|
2017
Q4 | – | Sell |
-214
| Closed | -$103K | – | 1650 |
|
|
2017
Q3 | $103K | Buy |
+214
| New | +$103K | ﹤0.01% | 1201 |
|